Genetic mutation doubles breast cancer risk-study

WASHINGTON, Oct 9 (Reuters) British researchers said they had found a new genetic mutation that doubled the risk of breast cancer in women who carry it.

The gene, called BRIP1, helps to repair damaged DNA -- like some of the other known breast cancer genes, researchers reported in this week's issue of the journal Nature Genetics.

And, as with the BRCA2 breast cancer gene, certain mutations in BRIP1 may cause a blood disease called Fanconi anemia, reported Dr Nazneen Rahman of the Institute of Cancer Research, in Sutton, Britain and colleagues.

''Breast cancer is approximately twice as common in sisters and mothers of affected individuals as in the general population,'' the researchers wrote.

Mutations in BRCA1, BRCA2, and TP53 raise the risk of breast cancer by 10- to 20-fold by age 60. Mutations in genes called CHEK2 and ATM roughly double the risk.

''Together, these susceptibility genes are estimated to account for up to 25 per cent of the familial risk of breast cancer,'' the researchers wrote.

They looked for genes that interact with the known breast cancer genes and found BRIP1, also known as BACH1.

They screened 1,212 women with breast cancer who did not have mutations in BRCA1 and BRCA2 and more than 2,000 women without breast cancer.

Nine of the breast cancer patients had mutations in the BRIP1 gene but just two of 2,081 cancer-free women did, Rahman's team found.

Breast cancer kills 500,000 people a year globally according to the World Health Organization.

REUTERS DKA BD1032